Urimar-t Caps Capsule
Product Images NDC 28595-224

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Urimar-t Caps (NDC 28595-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Urimar T Label)

Drug facts and labeling text panel for URIMAR-T CAPS urinary antiseptic capsules include dosage instructions, storage conditions, and precautions. Each capsule contains methenamine 120 mg, sodium phosphate monobasic 40.8 mg, phenyl salicylate 36.2 mg, methylene blue 10.8 mg, and hyoscyamine sulfate 0.12 mg. The label cautions about potential urine color changes and warns against use with serotonergic psychiatric medications. Manufactured by Allegis Pharmaceuticals, LLC, the package contains 60 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.